U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling by around 100 points on Thursday.
The Dow traded down 1.20% to 37,998.27 while the NASDAQ fell 0.85% to 15,578.58. The S&P 500 also fell, dropping, 0.70% to 5,035.88.
Check This Out: How To Earn $500 A Month From T-Mobile US Stock Ahead Of Q1 Earnings Report
Leading and Lagging Sectors
Materials shares rose by 0.7% on Thursday.
In trading on Thursday, communication services shares dipped by 4%.
Top Headline
Shares of Bristol Myers Squibb & Co BMY fell more than 8% during Thursday's session after the company swung to a loss in the first quarter.
The company posted first-quarter revenues of $11.9 billion, beating the consensus of $11.5 billion, an increase of 5% year-over-year. The company reported an adjusted EPS loss of $(4.40), compared to an income of $2.05 a year ago, beating the consensus loss of $(4.44).
Bristol Myers Squibb revised 2024 adjusted EPS guidance from $7.10-$7.40 to $0.40-$0.70 versus consensus of $0.66, reflecting the impact of recent transactions.
Equities Trading UP
- Impinj, Inc. PI shares shot up 26% to $152.87 after reporting better-than-expected first-quarter financial results.
- Shares of Ultralife Corporation ULBI got a boost, surging 21% to $10.56 after the company reported better-than-expected quarterly financial results.
- Processa Pharmaceuticals, Inc. PCSA shares were also up, gaining 44% to $2.34 after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced an $8 price target.
Equities Trading DOWN
- ATN International, Inc. ATNI shares dropped 34% to $19.00 as the company posted weak quarterly sales and slashed FY24 revenue forecast.
- Shares of Hertz Global Holdings, Inc. HTZ were down 20% to $4.6450 after the company mixed first-quarter financial results.
- JAKKS Pacific, Inc. JAKK was down, falling 18% to $19.33 following a wider-than-expected quarterly loss.
Also Check This Out: Meta Platforms To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Thursday
Commodities
In commodity news, oil traded up 0.6% to $83.28 while gold traded up 0.2% at $2,343.60.
Silver traded up 0.1% to $27.38 on Thursday, while copper rose 2% to $4.5445.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 fell 0.64%, London's FTSE 100 rose 0.48% while Spain's IBEX 35 Index fell 0.40% The German DAX fell 0.95% French CAC 40 fell 0.93% while Italy's FTSE MIB Index fell 0.97%.
Producer prices in Spain fell 8.2% year-over-year in March compared to a revised 8.5% decline in February. The GfK Consumer Climate Indicator for Germany climbed to -24.2 heading into May versus a revised reading of -27.3 in the prior period. UK's car production fell 27.1% to 59,467 units for March.
Asia Pacific Markets
Asian markets closed mostly higher on Thursday, with Japan's Nikkei 225 falling 2.16%, Hong Kong's Hang Seng Index gaining 0.48%, China's Shanghai Composite climbing 0.27% and India's S&P BSE Sensex gaining 0.66%.
Hong Kong's trade deficit increased to $45.0 billion in March from $40.6 billion in the year-ago month. The index of leading economic indicators in Japan came in unchanged at 111.8 in February, while index of coincident economic indicators was revised higher to 111.6 in February versus a flash reading of 110.9.
Economics
- U.S. initial jobless claims declined by 5,000 to 207,000 in the week ending April 20, compared to market estimates of 214,000.
- The U.S. economy grew an annualized 1.6% in the first quarter, marking a notable slowdown from the 3.4% rate in the final quarter of 2023. However, analysts were expecting a 2.5% growth.
- U.S. wholesale inventories fell by 0.4% month-over-month in March compared to a revised 0.4% gain in February.
- Pending home sales in the U.S. climbed by 3.4% month-over-month in March.
- The core price index for personal consumption expenditures increased by an annualized 3.7% in the first quarter versus a 2% gain in the prior three-month period.
- The EIA said US natural-gas supplies rose 92 billion cubic feet during the week ended April 19.
Now Read This: Jim Cramer: You’re ‘Dice Rolling’ With This Biopharma Stock, But Vista Energy Is ‘A Good Situation’
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.